Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Andrew Sudholz, CEO, Japara Healthcare Ltd
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Andrew Sudholz, CEO, Japara Healthcare Ltd
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Steering Toward Sustainable Profitability After Near Bankruptcy | Calin Rovinescu, CEO, Air Canada.
00:10:00
a long-time early-stage investor currently investing out of their 12th Fund|Brendan Dickinson,General Partner,Canaan Partners
00:10:00
Anton Paar Discusses Collaboration and Innovation in Battery Industry Transitions
00:10:00
Navigating Investment Opportunities Amid Rising Rates
00:10:00
Catalyzing the economic liberation of underserved communities in America by investing in businesses|Kesha Cash,General Partner,Impact America Fund
00:10:00
Helps entrepreneurs build companies to boldly transform|Lior Susan,Founding Partner,Eclipse Ventures
00:10:00
Momentus Stock Soars After Key National Security Agreement Termination
00:10:00
Denio Alves Lindo Discusses the Impact of Telecom Privatization on Desktop’s Growth and Expansion | Denio Alves ,CEO, Desktop S.A.
00:10:00
Building Momentum: Midas Gold's Path to a Promising Future
00:10:00
Michael Moe on the Rise of SPACs and GSV's Recent CLASS IPO in Digital Learning
00:10:00
Nodax: Danimer CEO Explores PHA's Potential for Single-Use Plastics | Stephen E. Croskrey - CEO of Danimer Scientific
00:10:00
Presentation Overview: Valuation Upside of BCI Minerals